Modeling to improve TB decision-making in the United States

Location

Baltimore, Maryland, US

Dates

10/01/2014 - 09/01/2019

PI

David Dowdy, MD, PhD, ScM

We are part of a large consortium that is constructing epidemic and economic models of TB and HIV in collaboration with the U.S. CDC to improve decision-making for TB control in the USA.

People

Kelly Dooley, MD, PhD
Faculty
Alice Zwerling, PhD, MSc
Postdoctoral Fellows
Colleen Hanrahan, PhD
Faculty
Jonathan Golub, PhD, MPH
Faculty
Emily Kendall, MD
Postdoctoral Fellows

Projects

A randomized trial of preventive therapy for...

We are evaluating the efficacy and cost-effectiveness of levofloxacin preventive therapy for pediatric contacts of MDR TB...

Read More

Scale-up and implementation of TB diagnostics...

We are evaluating the implementation, cost-effectiveness, and potential epidemiological impact of scaling up Xpert across 19...

Read More

FlexDx-TB: A flexible, user-friendly model of...

We have developed a web-based model that allows decision-makers to input local epidemiological and economic values and receive...

Read More

TBM-KIDS (India)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More

APT: Assessing PA-824 for Tuberculosis

A Phase 2 clinical trial of PA-824, an investigational nitroimidazole, as part of multidrug therapy for pulmonary TB; in...

Read More